How to manage uterine hemorrhage (uterine bleed)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To stop a uterine bleed, medical management with hormonal medications, such as combined oral contraceptives or tranexamic acid, is usually the first line of treatment, and in most cases, medical management should be trialed prior to pursuing more invasive therapies. For minor bleeding, rest and take over-the-counter pain relievers like ibuprofen (400-600mg every 6 hours) or naproxen (220-440mg every 12 hours), which can reduce both pain and blood flow 1.

Treatment Options

  • Hormonal medications, including combined oral contraceptives, progesterone-only pills, or tranexamic acid (Lysteda, typically 1300mg three times daily during heavy bleeding) are often prescribed to stabilize the endometrium and promote blood vessel constriction, while tranexamic acid prevents the breakdown of blood clots, allowing them to form more effectively and reduce bleeding 1.
  • In emergency situations, healthcare providers may administer intravenous estrogen, perform uterine artery embolization, or use intrauterine balloon tamponade.
  • For chronic bleeding, options include hormonal IUDs like Mirena, endometrial ablation, or hysterectomy in severe cases.

Underlying Conditions

It is essential to consider an underlying gynecological problem, such as interactions with other medications, an STD, pregnancy, or new pathologic uterine conditions (such as fibroids or polyps), and treat the condition or refer for care if identified 1.

Recent Guidelines

According to the most recent guidelines, medical management or uterine artery embolization (UAE) is usually appropriate for the initial therapy for a reproductive age patient with uterine fibroids and concurrent adenomyosis, symptomatic with heavy uterine bleeding or bulk symptoms 1.

From the Research

Medical Management of Uterine Bleeding

To stop a uterine bleed, medical management is often the first-line approach, as stated in the study 2. The treatment options vary depending on the acuity of the bleeding, the patient's medical history, and the underlying cause of the bleeding.

Treatment Options

Some viable options for treating abnormal uterine bleeding include:

  • Parenteral estrogen
  • Multidose combined oral contraceptive regimen
  • Multidose progestin-only regimen
  • Tranexamic acid, as mentioned in the studies 2 and 3
  • Levonorgestrel-releasing intrauterine system
  • Combined oral contraceptives
  • Continuous oral progestins
  • Nonsteroidal anti-inflammatory drugs (NSAIDs) to decrease menstrual bleeding, as stated in the study 2
  • Gonadotropin-releasing hormone agonists for patients with leiomyoma and abnormal uterine bleeding, as mentioned in the study 2

Progesterone and Progestogens

Progesterone and progestogens play a significant role in regulating intermenstrual bleeding and decreasing heavy menstrual bleeding, as discussed in the study 4. Medroxyprogesterone acetate (MPA) is a progestogen that can be used to treat abnormal uterine bleeding due to ovulatory dysfunction, as shown in the study 5. The study 5 found that a 10-day cyclic use of MPA was more effective in regulating the menstrual cycle and stopping abnormal uterine bleeding than a 15-day protocol.

Tranexamic Acid

Tranexamic acid (TXA) is another effective option for managing dysfunctional uterine bleeding, as demonstrated in the study 3. The study 3 compared the efficacy and safety of TXA with medroxyprogesterone acetate (MPA) and found that TXA was more effective in reducing blood loss and had a lower rate of lack of response during treatment.

Emergency Department Management

In emergency situations, it is essential to have a comprehensive understanding of the pathophysiology and etiologies of abnormal uterine bleeding to manage and treat patients effectively, as emphasized in the study 6. Emergency clinicians should be aware of the common causes of abnormal uterine bleeding and the approach to managing these patients in the emergency department.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The medical management of abnormal uterine bleeding in reproductive-aged women.

American journal of obstetrics and gynecology, 2016

Research

Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2006

Research

Progesterone and abnormal uterine bleeding/menstrual disorders.

Best practice & research. Clinical obstetrics & gynaecology, 2020

Research

Medroxyprogesterone Acetate for Abnormal Uterine Bleeding Due to Ovulatory Dysfunction: The Effect of 2 Different-Duration Regimens.

Medical science monitor : international medical journal of experimental and clinical research, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.